Cost may hinder use of new glaucoma drugs

First-line therapy for glaucoma in the United States is still the prescription of drop therapy. While some glaucoma specialists argue that selective laser trabeculoplasty or even a MIGS procedure in combination with cataract surgery is a competitive alternative for first-line therapy, those options are rarely employed in that fashion.
Nearly all American ophthalmologists start therapy in the patient with mild to moderate primary open-angle glaucoma with a topical drop. The preference of the majority for the first drop prescribed is generic latanoprost once daily at bedtime. Using the GoodRx

Full Story →